keyword
MENU ▼
Read by QxMD icon Read
search

Cytotec for labor induction

keyword
https://www.readbyqxmd.com/read/26435865/didelphys-uterus-a-case-report-and-review-of-the-literature
#1
Shadi Rezai, Pameela Bisram, Isamarie Lora Alcantara, Ruchi Upadhyay, Carla Lara, Malvina Elmadjian
Background. Mullerian duct anomalies (MDAs) are congenital defects of the female genital system that arise from abnormal embryological development of the Mullerian ducts. A didelphys uterus, also known as a "double uterus," is one of the least common amongst MDAs. This report discusses a case of didelphys uterus that successfully conceived, carried her pregnancy to term, and delivered vaginally without any significant complications. Case. Patient is a 29-year-old G2P0010 from Bangladesh, initially came a year prior in her first pregnancy, with spontaneous abortion (SAB)...
2015: Case Reports in Obstetrics and Gynecology
https://www.readbyqxmd.com/read/25317038/misoprostol-for-pre-term-labor-induction-in-the-second-trimester-role-of-medical-history-and-clinical-parameters-for-prediction-of-time-to-delivery
#2
Alexander di Liberto, Jan Endrikat, Sandra Frohn, Erich Solomayer, Kubilay Ertan
OBJECTIVE: Serious fetal malformations and/or chromosome aberrations detected by modern diagnostic tools in early pregnancy require discussions on induced abortion with pregnant women. Competent counseling includes prediction of the time needed for the whole abortion process. In an attempt to refine our predictions, we evaluated the impact of 11 medical history and clinical variables on time to delivery. MATERIAL AND METHODS: We performed a retrospective chart analysis on 79 women submitted for pre-term abortion because of fetal anomalies...
2014: Journal of the Turkish German Gynecological Association
https://www.readbyqxmd.com/read/20927722/vaginal-misoprostol-for-cervical-ripening-and-induction-of-labour
#3
REVIEW
G Justus Hofmeyr, A Metin Gülmezoglu, Cynthia Pileggi
BACKGROUND: Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue widely used for off-label indications such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology. OBJECTIVES: To determine the effects of vaginal misoprostol for third trimester cervical ripening or induction of labour. SEARCH STRATEGY: The Cochrane Pregnancy and Childbirth Group's Trials Register (November 2008) and bibliographies of relevant papers...
2010: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/18642564/-is-it-already-time-to-legalize-the-usage-of-cytotec-misoprostol-in-the-obstetrics-practice
#4
S Bozhinova
UNLABELLED: Cytotec (Misoprostol) is a prostaglandin E1 9(PgE1) analogue. Despite that it is not officially registered for obstetric and gynaecological targets, Cytotec (C) is widely used in this sphere. The author aims to study the effect and results from C application used for delivery (birth) induction, as well as means for cervical maturation. In order to reach this aim, beside the group of 45 pregnant women to who we applied C, we also reviewed the existing literature, which reported proves for C efficacy, pharma-kynetics and the safe aspects of its application (usage) in pregnancy...
2007: Akusherstvo i Ginekologii︠a︡
https://www.readbyqxmd.com/read/17273309/misoprostol-is-more-research-needed
#5
Mary Lou Moore
Misoprostol (Cytotec) is a synthetic prostaglandin E1 analogue that was designed for the prevention and treatment of peptic ulcer associated with the use of nonsteroidal anti-inflammatory drugs. In obstetrics, misoprostol has been administered for induction of first and second trimester abortion, for induction of labor in the third trimester, and to control postpartum hemorrhage. None of these uses has been approved by the Food and Drug Administration. Nevertheless, misoprostol is widely used in the United States and throughout the world...
2002: Journal of Perinatal Education
https://www.readbyqxmd.com/read/16313050/-misoprostol-and-induction-of-labour
#6
COMPARATIVE STUDY
V Porozhanova, D Sampat, K Porozhanova
UNLABELLED: Misoprostol (Cytotec) is a synthetic analogue of PGE1, not yet registered for Obstetric practice. Vowing to its low cost and high efficacy there is marked interest towards this medicament. MATERIALS AND METHODS: 47 patients with induction of labour are distributed into two groups: Gr.A (n = 25), receiving Misoprostol and Gr.B (n = 22) with Oxytocin in perfusion. RESULTS: Protocol of treatment with PGE, includes 50 microg per os every 2 hrs...
2005: Akusherstvo i Ginekologii︠a︡
https://www.readbyqxmd.com/read/15814391/pre-induction-cervical-ripening-transcervical-foley-catheter-versus-intravaginal-misoprostol
#7
RANDOMIZED CONTROLLED TRIAL
O A Adeniji, A Oladokun, O Olayemi, O I Adeniji, A A Odukogbe, O Ogunbode, C O Aimakhu, A O Omigbodun, A O Ilesanmi
The object of this study was to compare the effectiveness of the intravaginal Misoprostol and transcervical Foley catheters as pre-induction cervical ripening agents, to estimate the proportion of patients achieving vaginal delivery and to compare the complications of labour and foetal outcome between the two groups. The study was a prospective, randomised study of pregnant women, with singleton pregnancies who presented for antenatal care and delivery at the University College Hospital (UCH), Ibadan, Nigeria...
February 2005: Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/12867908/induction-of-labor-the-misoprostol-controversy
#8
REVIEW
Alisa B Goldberg, Deborah A Wing
Misoprostol (Cytotec) is safe and effective for induction of labor, although it is not approved by the Food and Drug Administration (FDA) for use in pregnancy. In August 2000, the manufacturer of misoprostol warned against its use in pregnancy because of its abortifacient properties and cited reports of maternal and fetal deaths when misoprostol was used to induce labor, fueling the misoprostol controversy. More than 45 randomized trials including more than 5400 women have found vaginal misoprostol to be more effective than oxytocin or vaginal prostaglandin E2 at effecting vaginal delivery within 24 hours...
July 2003: Journal of Midwifery & Women's Health
https://www.readbyqxmd.com/read/12834952/acog-committe-opinion-new-u-s-food-and-drug-administration-labeling-on-cytotec-misoprostol-use-and-pregnancy-number-283-may-2003
#9
(no author information available yet)
On April 17, 2002, the U.S. Food and Drug Administration approved a new label for the use of Cytotec (misprostol) during pregnancy. The new labeling does not contain claims regarding the efficacy and/or safety of Cytotec when it is used for cervical ripening for the induction of labor nor does it stipulate doses or dosing intervals. Therefore, the Committee on Obstetric Practice reminds Fellows that this agent should be used as previously recommended.
July 2003: International Journal of Gynaecology and Obstetrics
https://www.readbyqxmd.com/read/12738178/acog-committee-opinion-number-283-may-2003-new-u-s-food-and-drug-administration-labeling-on-cytotec-misoprostol-use-and-pregnancy
#10
(no author information available yet)
On April 17, 2002, the U.S. Food and Drug Administration approved a new label for the use of Cytotec (misoprostol) during pregnancy. The new labeling does not contain claims regarding the efficacy and/or safety of Cytotec when it is used for cervical ripening for the induction of labor nor does it stipulate doses or dosing intervals. Therefore, the Committee on Obstetric Practice reminds Fellows that this agent should be used as previously recommended.
May 2003: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/12592272/comparative-efficacy-and-cost-of-the-prostaglandin-analogs-dinoprostone-and-misoprostol-as-labor-preinduction-agents
#11
RANDOMIZED CONTROLLED TRIAL
Patrick S Ramsey, Denise Y Harris, Paul L Ogburn, Robert H Heise, Paul M Magtibay, Kirk D Ramin
OBJECTIVE: The purpose of this study was to compare the relative efficacy and cost of three commercially available prostaglandin analogs, misoprostol (Cytotec), dinoprostone gel (Prepidil), and dinoprostone insert (Cervidil), as labor preinduction agents. STUDY DESIGN: One-hundred eleven women with an unfavorable cervix who underwent labor induction were assigned randomly to receive either misoprostol 50 microg every 6 hours for two doses, dinoprostone gel 0.5 mg every 6 hours for two doses, or dinoprostone insert 10 mg for one dose intravaginally...
February 2003: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/12535398/vaginal-misoprostol-for-cervical-ripening-and-induction-of-labour
#12
REVIEW
G J Hofmeyr, A M Gülmezoglu
BACKGROUND: Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue marketed for use in the prevention and treatment of peptic ulcer disease. It is inexpensive, easily stored at room temperature and has few systemic side effects. It is rapidly absorbed orally and vaginally. Although not registered for such use, misoprostol has been widely used for obstetric and gynaecological indications, such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology...
2003: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/11982272/mother-jones-magazine-questions-cytotec-for-labor-induction
#13
(no author information available yet)
No abstract text is available yet for this article.
April 2001: AWHONN Lifelines
https://www.readbyqxmd.com/read/11686970/vaginal-misoprostol-for-cervical-ripening-and-induction-of-labour
#14
REVIEW
G J Hofmeyr, A M Gulmezoglu
BACKGROUND: Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue marketed for use in the prevention and treatment of peptic ulcer disease. It is inexpensive, easily stored at room temperature and has few systemic side effects. It is rapidly absorbed orally and vaginally. Although not registered for such use, misoprostol has been widely used for obstetric and gynaecological indications, such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology...
2001: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/11279698/vaginal-misoprostol-for-cervical-ripening-and-induction-of-labour
#15
REVIEW
G J Hofmeyr, A M Gulmezoglu
BACKGROUND: Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue marketed for use in the prevention and treatment of peptic ulcer disease. It is inexpensive, easily stored at room temperature and has few systemic side effects. It is rapidly absorbed orally and vaginally. Although not registered for such use, misoprostol has been widely used for obstetric and gynaecological indications, such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology...
2001: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/11194687/comparison-between-vaginal-misoprostol-and-cervical-dinoprostone-for-cervical-ripening-and-labor-induction
#16
RANDOMIZED CONTROLLED TRIAL
R Neiger, P C Greaves
OBJECTIVE: To compare the efficacy of intravaginal misoprostol (Cytotec) to intracervical dinoprostone (Prepidil) for pre-induction cervical ripening. METHODS: Sixty-one patients admitted for induction of labor, whose cervices were unfavorable (Bishop score: 4), were randomly assigned to either intravaginal placement of a 50 micrograms misoprostol tablet or intracervical administration of dinoprostone gel. RESULTS: Eighteen women (56%) in the misoprostol group and five (17%) in the dinoprostone group achieved cervical ripening within 12 hours (P = 0...
January 2001: Tennessee Medicine: Journal of the Tennessee Medical Association
https://www.readbyqxmd.com/read/10715910/-using-of-misoprostol-for-preinduction-and-induction-of-labor-in-term-pregnancy
#17
B Leszczyńska-Gorzelak, M Laskowska, J Oleszczuk
UNLABELLED: Labour induction is frequently indicated in women with an unfavourable cervix. Oxytocin and prostaglandins are the most common drugs used for labour induction. Induction of labour with prostaglandins offers the advantage of promoting both cervical ripening and myometrial contractility. The purpose of the study was to evaluate the safety and efficacy intravaginal administration prostaglandin E1 methyl analogue, misoprostol in cervical ripening and induction of labour in term pregnancy and in women with unfavourable cervix (Bishop score < = 4)...
December 1999: Ginekologia Polska
https://www.readbyqxmd.com/read/10705313/-induction-of-labor-by-misoprostol-an-analog-of-pge1-a-prospective-study-of-200-cases
#18
COMPARATIVE STUDY
T Chraibi, A Aboulfalah, W Bisbis, M Noun, N Matar, N Samouh, A Himmi
We carried out a prospective study of 200 pregnant women who required induction of labor at full term, at the Lalla Meryem maternity unit of the Ibn Rochd University Hospital, Casablanca, between January 1st 1996 and June 30th 1997. The aim of this study was to evaluate the efficacy, tolerance and acceptance of misoprostol (Cytotec) as a drug for inducing labor in unfavorable conditions (Bishop < 5). Misoprostol (a PGE1 analog) was administered to the women via the vagina, with a dose of 1/4 tb (50 mg) given every 6 hours, and a maximum of 3 doses (150 mg)...
November 1999: Santé: Cahiers D'étude et de Recherches Francophones
https://www.readbyqxmd.com/read/10488313/misoprostol-cytotec-for-labor-induction-a-cautionary-tale
#19
M Wagner
No abstract text is available yet for this article.
1999: Midwifery Today with International Midwife
https://www.readbyqxmd.com/read/9704771/induction-of-labor-with-misoprostol-for-premature-rupture-of-membranes-beyond-thirty-six-weeks-gestation
#20
RANDOMIZED CONTROLLED TRIAL
D A Wing, R H Paul
OBJECTIVE: Our purpose was to compare vaginally administered misoprostol (Cytotec) with intravenous oxytocin for labor induction in women with premature rupture of membranes beyond 36 weeks' gestation. STUDY DESIGN: Two hundred subjects with rupture of membranes without labor were randomly assigned to receive vaginally administered misoprostol or intravenous oxytocin. Twenty-five micrograms of misoprostol (Cytotec) was placed in the posterior vaginal fornix. If cervical ripening (Bishop score of > or = 8 or cervical dilatation of > or = 3 cm) or active labor did not occur, a single repeat dose of misoprostol was given 6 hours later...
July 1998: American Journal of Obstetrics and Gynecology
keyword
keyword
8415
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"